3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Burkitt Lymphoma
5
Prostatic Neoplasms
4
Neoplasms
4
Leukemia, Biphenotypic, Acute
4
Ovarian Neoplasms
3
Lymphoma, Follicular
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Metastatic Castration-resistant Prostate Cancer
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lymphoma
2
Hodgkin Disease
2
Endometrial Neoplasms
2
Down Syndrome
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Myasthenia Gravis
1
Lymphoma, T-Cell, Peripheral
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Immunoblastic Lymphadenopathy
1
Enteropathy-Associated T-Cell Lymphoma
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Bulbo-Spinal Atrophy, X-Linked
1
Biliary Tract Neoplasms
1
Adrenal Insufficiency
1
Interventions
Lenalidomide
6
Dexamethasone
6
Cyclophosphamide
5
Bortezomib
5
fludarabine
3
carfilzomib
3
belantamab mafodotin
3
pomalidomide
2
fludarabine phosphate
2
Melphalan
2
Etoposide
2
pembrolizumab
1
isatuximab
1
elotuzumab
1
daratumumab
1
Whole-Body Irradiation
1
Thalidomide
1
Tacrolimus
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Methotrexate
1
Exercise
1
Equipment and Supplies
1
Doxorubicin
1
Cyclosporine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Plasma Cell
×
Prednisolone
×
90 days
×
Clear all
No trials found.